Extendicare Inc. EXE

Updated: 12 Jun 2026

TSX | Senior care and home healthcare

No signal published yet

We already track Extendicare and collect the news. No signal is published yet — follow the company free and we will email you when that changes, or run a quick check now.

Follow Extendicare free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Free
No email, no account, no signup.
Exchange
TSX
Sector
Senior care and home healthcare
We're already tracking Extendicare Inc. — here are the latest events we've registered

Recent News

  • In April 2026, Extendicare completed the acquisition of CBI Home Health for CAD 570 million and closed a CAD 450 million senior unsecured note offering. The company reported Q1 2026 results in May 2026, with revenue increasing 24.2% year-over-year, driven by organic growth and acquisitions.

What Firelda Watch includes for Extendicare Inc.

Add the company to your watchlist and get all of this automatically.

  • Free: 3 companies on your watchlist
  • Change history and monitoring for every company you follow
  • Sunday weekly brief — a short weekly roundup
  • Watch/Ultra: same-day email when something material happens
Want to see what a finished analysis looks like?
View a sample analysis
This is a real Firelda analysis. Your analysis of Extendicare Inc. will be delivered in the same format.

Want to follow Extendicare Inc.? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.

Follow Extendicare free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Extendicare Inc. EXE
Extendicare — follow and we'll monitor it
Follow Extendicare free Follow free
Firelda provides general information and analysis, not personal investment advice. Content does not consider your financial situation or goals. Investments can rise and fall in value. Always do your own research.